Loading
IA
ImmunoPrecise Antibodies Ltd. Stock: price and insider trades · Canada
ImmunoPrecise Antibodies Ltd.: what insiders have been doing
Every trade that managers of ImmunoPrecise Antibodies Ltd. disclose to SEDI is tracked on this page. No insider at ImmunoPrecise Antibodies Ltd. has published a filing in the past twelve months. The most recent one dates from 9 July 2025.
The full history, which starts in 2019, counts 262 purchases against 16 sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Insider Decl.
313
Thresholds
n/a
Buy Volume
€785,937
262 ops. · all time
Sell Volume
€2M
16 ops. · all time
Who traded when
BuySaleDirk Medard Helena Van Hyfte4 buys
Ingrid Maria Henri Brands4 buys
Jennifer Lynne Bath2 buys
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 9 July 2025
Declarations313 total
Common SharesTSXSEDI:4545458
58,591 shares@ CA$0.40Common SharesTSXSEDI:4420210
Canonical exit: 16 Mar 2025 (T+90)
29,747 shares@ CA$0.40Common SharesTSXSEDI:4420208
Canonical exit: 13 Mar 2025 (T+90)
27,013 shares@ CA$0.43Common SharesTSXSEDI:4420197
Canonical exit: 17 Mar 2025 (T+90)
58,591 shares@ CA$0.40Common SharesTSXSEDI:4420196
Canonical exit: 16 Mar 2025 (T+90)
12,300 shares@ CA$0.425Common SharesTSXSEDI:4420189
Canonical exit: 16 Mar 2025 (T+90)
27,013 shares@ CA$0.43Common SharesTSXSEDI:4420212
Canonical exit: 17 Mar 2025 (T+90)
147,149 shares@ CA$0.40Common SharesTSXSEDI:4420206
Canonical exit: 12 Mar 2025 (T+90)
225,000 shares@ CA$0.40Common SharesTSXSEDI:4420188
Canonical exit: 16 Mar 2025 (T+90)
147,150 shares@ CA$0.40Common SharesTSXSEDI:4420194
Canonical exit: 12 Mar 2025 (T+90)
29,746 shares@ CA$0.40Common SharesTSXSEDI:4420195
Canonical exit: 13 Mar 2025 (T+90)
9,156 shares@ CA$0.8399Common SharesTSXSEDI:4354834
Canonical exit: 30 Oct 2024 (T+90)
100 shares@ CA$0.8394Common SharesTSXSEDI:4354832
Canonical exit: 30 Oct 2024 (T+90)
400 shares@ CA$0.839Common SharesTSXSEDI:4354831
Canonical exit: 30 Oct 2024 (T+90)
400 shares@ CA$0.8098Common SharesTSXSEDI:4354827
Canonical exit: 30 Oct 2024 (T+90)
1,944 shares@ CA$0.8099Common SharesTSXSEDI:4354828
Canonical exit: 30 Oct 2024 (T+90)
3,000 shares@ CA$1.51811.1% of flowCommon SharesTSXSEDI:4287196
Canonical exit: 24 Jun 2024 (T+90)
4,211 shares@ CA$1.55971.6% of flowCommon SharesTSXSEDI:4288033
Canonical exit: 25 Jun 2024 (T+90)
739 shares@ CA$1.560.3% of flowCommon SharesTSXSEDI:4288031
Canonical exit: 25 Jun 2024 (T+90)
1,000 shares@ CA$1.53850.4% of flowCommon SharesTSXSEDI:4287195
Canonical exit: 23 Jun 2024 (T+90)
50 shares@ CA$1.570.0% of flowCommon SharesTSXSEDI:4288032
Canonical exit: 25 Jun 2024 (T+90)
5,000 shares@ CA$1.5299100.0% of flowCommon SharesTSXSEDI:4286654
Canonical exit: 24 Jun 2024 (T+90)
3,000 shares@ CA$1.48991.1% of flowCommon SharesTSXSEDI:4285466
Canonical exit: 20 Jun 2024 (T+90)
1,000 shares@ CA$1.40850.4% of flowCommon SharesTSXSEDI:4284691
Canonical exit: 19 Jun 2024 (T+90)
5,000 shares@ CA$1.401.8% of flowCommon SharesTSXSEDI:4284697
Canonical exit: 19 Jun 2024 (T+90)
25 of 313 declarations
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. is a company focused on the development of therapeutic and diagnostic antibodies. It operates on the Toronto Stock Exchange (XTSE).
